Stock Analysts

CME Reaches 52-Week High

On Tuesday, shares of CME Group Inc. ( CME ) reached a 52-week high of $65.49. The momentum was driven by improved volumes and fair liquidity, led by a reduction in debt during the first quarter of 2013 […]

Stock Analysts

P&G Maintained at Neutral

On May 28, we maintained a Neutral recommendation on T he Procter & Gamble Company ( PG ), following mixed third-quarter fiscal 2013 results announced last month. Why the Neutral Recommendation? On Apr 24, P&G reported mixed fiscal third-quarter results beating earnings but missing out on sales […]

Mergers & Acquisitions

Specialty Operations Solutions joins The WorkingBuildings Companies

Specialty Operations Solutions joins The WorkingBuildings Companies WorkingBuildings expands its capabilities and service offerings through the acquisition of Specialty Operations Solutions PR Newswire ATLANTA, May 29, 2013 ATLANTA , May 29, 2013 /PRNewswire/ — The WorkingBuildings Companies, a leading provider of comprehensive Owner-based solutions for the built environment, is pleased to announce the acquisition of Specialty Operations Solutions (SOS), a national provider of research and laboratory services. This addition to the firm strengthens The WorkingBuildings Companies’ position as one of the fastest-growing comprehensive professional services firm in the world and expands their existing service offerings. The WorkingBuildings Companies features six specialized divisions of service dedicated to providing facility Owners with quality processes for the built environment […]

FDA Approval

Two new GSK oral oncology treatments, BRAF-inhibitor Tafinlar (dabrafenib) capsules and the first MEK-inhibitor Mekinist™ (trametinib) tablets, approved by FDA as single-agent therapies

Two new GSK oral oncology treatments, BRAF-inhibitor Tafinlar (dabrafenib) capsules and the first MEK-inhibitor Mekinist™ (trametinib) tablets, approved by FDA as single-agent therapies – Both approved for unresectable or metastatic melanoma with BRAF V600E mutation; Mekinist also approved for BRAF V600K mutation PR Newswire LONDON and PHILADELPHIA, May 29, 2013 LONDON and PHILADELPHIA , May 29, 2013 /PRNewswire/ — GlaxoSmithKline plc [LSE/NYSE: GSK] announced today that the U.S. Food and Drug Administration (FDA) has approved both TAFINLAR (dabrafenib) and MEKINIST™ (trametinib). Tafinlar is indicated as a single-agent oral treatment for unresectable melanoma (melanoma that cannot be removed by surgery) or metastatic melanoma (melanoma which has spread to other parts of the body) in adult patients with BRAF V600E mutation […]

Mergers & Acquisitions

NV Energy, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By MidAmerican Energy Holdings Company, A Subsidiary Of Berkshire Hathaway Inc.

NV Energy, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By MidAmerican Energy Holdings Company, A Subsidiary Of Berkshire Hathaway Inc. PR Newswire NEW YORK, May 29, 2013 NEW YORK , May 29, 2013 /PRNewswire/ — Bernstein Liebhard LLP is investigating whether the Board of Directors of NV Energy, Inc. […]

Stock Analysts

Amgen-Astellas Collaborate

Amgen ( AMGN ) recently announced a strategic alliance with Japanese company, Astellas Pharma Inc. ( ALPMY ), for the development and commercialization of new drugs for a wide range of diseases in Japan. The pipeline candidates covered under the alliance include four biologics and a small molecule targeting the cardiovascular, bone disease and cancer markets. […]

Stock Analysts

H-P Secures London Deluxe Contract

Hewlett-Packard Company ( HPQ ) is winning contracts at regular intervals, the latest being a deal with London’s Deluxe Digital Cinema. The company will be working in collaboration with HP to improve the speed, security and quality of its feature films and also the trailer distribution process. Under this seven-year agreement, the HP Business Exchange Services (BES) content distribution systems will be used by Deluxe Digital in combination with HP Enterprise Cloud Services which will help the distribution of feature films from an initial 3,000 cinemas across Europe in the next 18 months. […]

Stock Analysts

Setback for Valeant Pharma

Valeant Pharmaceuticals ( VRX ) recently suffered a setback when the US Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) to the company regarding its New Drug Application (NDA) for its anti-fungal candidate IDP-108 (efinaconazole). Valeant Pharma filed the NDA for IDP-108 in the US in Jul 2012. Valeant Pharma is seeking FDA approval for IDP-108 for a potential new treatment of onychomycosis, a fungal infection of the fingernails and toenails, primarily in elders […]

Stock Analysts

Chicago Bridge Signs Contract with EPA

Chicago Bridge & Iron ( CBI ) recently signed a $160-million worth indefinite delivery/indefinite quantity contract with the Environmental Protection Agency (EPA). Per the terms of the contract, CBI will be providing environmental remediation services according to the orders received by Region 9 of EPA. This region includes states like Arizona, Nevada, California, Hawaii, tribal nations and U.S […]

Stock Analysts

Encouraging Data from Alkermes

Alkermes plc ( ALKS ) recently presented encouraging data from a phase I study, which evaluated its schizophrenia candidate, ALKS 3831. Data was presented at the 53rd annual meeting of the New Clinical Drug Evaluation Unit (NCDEU) held in the US. […]

Stock Analysts

Hyatt Set to Expand in Seoul

In a bid to expand in the lucrative Asian market, leading global hotel chain Hyatt Hotels Corporation ( H ) recently decided to open a Hyatt Place branded hotel, Hyatt Place Seoul in Seoul, South Korea. In this regard, Hyatt inked a management agreement with KY Development Co., Ltd. […]

Mergers & Acquisitions

Priceline.com Announces Proposed $1 Billion Private Offering of Convertible Senior Notes and Authorization to Repurchase Shares of Common Stock

Priceline.com Announces Proposed $1 Billion Private Offering of Convertible Senior Notes and Authorization to Repurchase Shares of Common Stock PR Newswire NORWALK, Conn., May 29, 2013 NORWALK, Conn. , May 29, 2013 /PRNewswire/ — Priceline.com Incorporated (Nasdaq: PCLN) announced today its intention to offer, subject to market and other conditions, up to $1 billion principal amount of Convertible Senior Notes due 2020 through a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. In certain circumstances, the notes may be converted into cash up to their principal amount, and into shares of priceline.com common stock and/or cash at the Company’s election for the conversion value above the principal amount, if any […]